Quick Answer
IONIS PHARMACEUTICALS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $943.71 million for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +33.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), IONIS PHARMACEUTICALS INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 934.8%.
- Historical annual values: Fiscal year 2025: $943.71 million | Fiscal year 2024: $705.14 million | Fiscal year 2023: $787.65 million | Fiscal year 2022: $587.37 million | Fiscal year 2021: $810.46 million | Fiscal year 2020: $729.26 million | Fiscal year 2019: $1.12 billion | Fiscal year 2018: $599.67 million | Fiscal year 2017: $514.18 million | Fiscal year 2016: $372.78 million | Fiscal year 2015: $91.20 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: